Published in Environ Health Perspect on July 01, 1998
Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet (2008) 7.36
Pharmacogenomics: the promise of personalized medicine. AAPS PharmSci (2000) 2.63
A bold new direction for environmental health research. Am J Public Health (2001) 1.62
The Environmental Polymorphisms Registry: a DNA resource to study genetic susceptibility loci. Hum Genet (2008) 1.18
Human exposure assessment and the National Toxicology Program. Environ Health Perspect (1998) 1.14
Pharmacogenomics. Interview by Clare Thompson. BMJ (1999) 0.93
The Environmental Polymorphism Registry: a unique resource that facilitates translational research of environmental disease. Environ Health Perspect (2011) 0.92
Application of genomics to toxicology research. Environ Health Perspect (2002) 0.89
Gene-environment interactions in the development of complex disease phenotypes. Int J Environ Res Public Health (2008) 0.86
Considerations for Using Genetic and Epigenetic Information in Occupational Health Risk Assessment and Standard Setting. J Occup Environ Hyg (2015) 0.86
Toxicogenomics: "the call of the wild chip". Environ Health Perspect (2001) 0.83
Knowledge building insights on biomarkers of arsenic toxicity to keratinocytes and melanocytes. Biomark Insights (2012) 0.80
An occupational reproductive research agenda for the third millennium. Environ Health Perspect (2003) 0.77
Pharmacogenomics. West J Med (1999) 0.77
Epidemiology faces its limits. Science (1995) 12.39
Polymorphic hydroxylation of Debrisoquine in man. Lancet (1977) 9.36
The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell (1988) 7.76
DNA excision repair. Annu Rev Biochem (1996) 6.71
Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst (1994) 5.92
Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science (1996) 3.53
The failure of academic epidemiology: witness for the prosecution. Am J Epidemiol (1997) 3.41
Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics (1994) 2.55
Environment and cancer: who are susceptible? Science (1997) 2.18
Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A (1996) 2.08
Relationships between DNA repair and transcription. Annu Rev Biochem (1996) 1.90
High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst (1994) 1.81
Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res (1991) 1.76
Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol (1997) 1.66
Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev (1994) 1.60
The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol (1989) 1.56
The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol (1996) 1.53
Environment institute lays plans for gene hunt. Science (1997) 1.52
Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J (1996) 1.52
Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A (1995) 1.41
Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35
In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun (1997) 1.34
Breast cancer risk and environmental exposures. Environ Health Perspect (1997) 1.23
Role of cytochrome P450 enzymes in drug-drug interactions. Adv Pharmacol (1997) 1.16
Xeroderma pigmentosum, Cockayne's syndrome, helicases, and DNA repair: what's the relationship? Cell (1992) 1.13
Toxicological approaches to complex mixtures. Environ Health Perspect (1993) 1.07
Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res (1996) 1.06
A critical review of the genotoxic potential of electric and magnetic fields. Mutat Res (1993) 1.01
Role of transcription-coupled DNA repair in susceptibility to environmental carcinogenesis. Environ Health Perspect (1996) 0.92
Aflatoxin B1 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase. Chem Res Toxicol (1997) 0.85
Role of cytochrome P450 enzymes in drug-drug interactions. Adv Pharmacol (1997) 1.16